Determination of ondansetron in plasma and its pharmacokinetics in the young and elderly.
Ondansetron is a 5-hydroxytryptamine3 receptor antagonist for the treatment of chemotherapy- and radiotherapy-induced nausea and emesis. A sensitive, accurate, and precise HPLC method for the determination of ondansetron in plasma is described. Samples are prepared by solid-phase extraction and, after chromatography of the extracts on a silica analytical column, ondansetron is detected by UV absorbance at 305 nm. The method is sensitive down to 1 ng/mL, at which concentration the coefficient of variation was 6.2% in a single assay run. Repeated analyses of quality control samples, nominally at 2 ng/mL, were carried out over a number of assay runs with a coefficient of variation of 5.5%. The method is specific for ondansetron with respect to endogenous plasma components, identified phase I metabolites, and some co-administered chemotherapeutic drugs. In sustained use over several months, and in support of the clinical development of ondansetron, the method has been shown to be robust. An application of the assay in the investigation of the pharmacokinetics of ondansetron in the young and elderly is described.
Colthup
P V
PV
Department of Biochemical Pharmacology, Glaxo Group Research Limited, Ware, Hertfordshire, U.K.
Felgate
C C
CC
Palmer
J L
JL
Scully
N L
NL
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000932:Antiemetics / Q000097:blood / Q000493:pharmacokinetics*; D006801:Humans; D007093:Imidazoles / Q000097:blood / Q000493:pharmacokinetics*; D017294:Ondansetron; D012702:Serotonin Antagonists / Q000097:blood / Q000493:pharmacokinetics*
D000932:Antiemetics; D007093:Imidazoles; D012702:Serotonin Antagonists; D017294:Ondansetron